サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1754164

静注（IV）用イブプロフェン市場レポート：製品用量、適応症、年齢層、地域別、2025年～2033年

Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 141 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.80円
静注（IV）用イブプロフェン市場レポート：製品用量、適応症、年齢層、地域別、2025年～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の静注（IV）用イブプロフェン市場規模は2024年に73億米ドルに達しました。今後、IMARC Groupは、2033年には132億米ドルに達し、2025～2033年の成長率（CAGR）は6.45％になると予測しています。

イブプロフェンは非ステロイド性抗炎症薬（NSAID）に属し、炎症、疼痛、発熱の治療に使用されます。プロスタグランジン（PG）の合成に必要なシクロオキシゲナーゼCOZ-1およびCOX-2酵素を阻害します。静注（IV）用イブプロフェンは、軽度から重度の不快感を和らげるために単独で、または他の薬と一緒に使用されます。炎症を引き起こす特定の天然物質の体内生産をブロックするために、静脈に直接注射します。麻薬性鎮痛薬の必要量を減らし、優れた安全性プロファイルで痛みのレベルを下げるのに役立ちます。また、イブプロフェンの静脈内投与は、整形外科手術や腹部手術、発熱時の疼痛コントロールを改善し、オピオイド製剤の使用量を減らすのに役立ちます。

静注（IV）用イブプロフェン市場動向：

高齢者が着実に増加し、世界中で関節炎、心血管疾患（CVDs）、がんの有病率が増加していることが、市場に明るい展望をもたらしています。これに伴い、炎症性疾患、リウマチ性疾患、軽度から中等度の疼痛、発熱、月経困難症、変形性関節症などの管理・治療に広く製品が採用されていることが、市場の成長を後押ししています。さらに、多忙な勤務スケジュールや不健康なライフスタイル、それに伴う身体活動や適切な栄養摂取の減少が、慢性疾患の発生率の上昇につながっており、これも成長を促す要因となっています。これとは別に、軽度の発熱、歯の痛み、胃腸の痛み、小児科における動脈管開存の治療への製品利用が増加していることも、市場成長に弾みをつけています。さらに、点滴イブプロフェンは筋肉痛やリウマチ痛、腰痛、神経痛、捻挫、挫傷、スポーツ外傷、筋骨格系疾患の緩和にも使用され、市場成長を促進しています。さらに、膝や股関節の置換手術後の整形外科患者において、疼痛やモルヒネの使用を軽減するためにイブプロフェンの静脈内投与に対する需要が増加していることも、市場成長にプラスの影響を与えています。その他の要因としては、ヘルスケアインフラの大幅な改善、個人の健康意識の高まり、消費者の支出能力の上昇などが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主な質問

  • 2024年の世界の静注（IV）用イブプロフェン市場規模は？
  • 2025-2033年における静注（IV）用イブプロフェンの世界市場予測成長率は？
  • 静注（IV）用イブプロフェンの世界市場を牽引する主要因は？
  • 静注（IV）用イブプロフェンの世界市場におけるCOVID-19の影響は？
  • 静注（IV）用イブプロフェンの世界市場における適応症別の内訳は？
  • 静注（IV）用イブプロフェンの世界市場における年齢層別の内訳は？
  • 静注（IV）用イブプロフェンの世界市場における主要地域は？
  • 静注（IV）用イブプロフェンの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の静注（IV）用イブプロフェン市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品用量別

  • 100mgの用量
  • 200mgの用量
  • 400mgの用量
  • 800mgの用量

第7章 市場内訳：適応症別

  • 痛み/炎症
  • 熱

第8章 市場内訳：年齢別

  • 小児
  • 大人

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Cumberland Pharmaceuticals Inc.
    • Hyloris Pharmaceuticals SA
    • Recordati Rare Diseases Inc.
    • VALMOR Laboratories CA
    • Xgen Pharmaceuticals Djb Inc.
図表

List of Figures

  • Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2024
  • Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2024
  • Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
  • Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
  • Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million USD), 2025-2033
  • Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
  • Table 7: Global: Intravenous Ibuprofen Market: Key Players
目次
Product Code: SR112025A6440

The global intravenous (IV) ibuprofen market size reached USD 7.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.45% during 2025-2033.

Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.

Intravenous (IV) Ibuprofen Market Trends:

The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product Dose:

  • 100 Mg Dose
  • 200 Mg Dose
  • 400 Mg Dose
  • 800 Mg Dose

Breakup by Indication:

  • Pain/Inflammatory
  • Fever

Breakup by Age Group:

  • Pediatrics
  • Adults

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global Intravenous (IV) ibuprofen market in 2024?
  • 2.What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2025-2033?
  • 3.What are the key factors driving the global Intravenous (IV) ibuprofen market?
  • 4.What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
  • 5.What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
  • 6.What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
  • 7.What are the key regions in the global Intravenous (IV) ibuprofen market?
  • 8.Who are the key players/companies in the global Intravenous (IV) ibuprofen market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Ibuprofen Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Dose

  • 6.1 100 Mg Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 200 Mg Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 400 Mg Dose
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 800 Mg Dose
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Pain/Inflammatory
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fever
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 Pediatrics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adults
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Cumberland Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hyloris Pharmaceuticals SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Recordati Rare Diseases Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 VALMOR Laboratories CA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Xgen Pharmaceuticals Djb Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio